These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37047803)

  • 1. Effect of Cytomegalovirus Reactivation on Inflammatory Status and Mortality of Older COVID-19 Patients.
    Giacconi R; Cardelli M; Piacenza F; Pierpaoli E; Farnocchia E; Di Rosa M; Bonfigli AR; Casoli T; Marchegiani F; Marcheselli F; Recchioni R; Stripoli P; Galeazzi R; Cherubini A; Fedecostante M; Sarzani R; Di Pentima C; Giordano P; Antonicelli R; Provinciali M; Lattanzio F
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
    Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
    J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
    Gatto I; Biagioni E; Coloretti I; Farinelli C; Avoni C; Caciagli V; Busani S; Sarti M; Pecorari M; Gennari W; Guaraldi G; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Cossarizza A; Girardis M;
    Intensive Care Med; 2022 Jun; 48(6):706-713. PubMed ID: 35583676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
    Tassaneeyasin T; Sungkanuparph S; Srichatrapimuk S; Charoensri A; Thammavaranucupt K; Jayanama K; Kirdlarp S
    PLoS One; 2024; 19(5):e0303995. PubMed ID: 38771836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.
    Boers LS; van Someren Gréve F; van Hattem JM; de Brabander J; Zwaan T; van Willigen H; Cornelissen M; de Jong M; van der Poll T; Duitman J; Schinkel J; Bos LDJ;
    Intensive Care Med; 2024 Aug; 50(8):1251-1264. PubMed ID: 39017695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Pulmonary Aspergillosis and
    Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.
    Heininger A; Haeberle H; Fischer I; Beck R; Riessen R; Rohde F; Meisner C; Jahn G; Koenigsrainer A; Unertl K; Hamprecht K
    Crit Care; 2011; 15(2):R77. PubMed ID: 21362193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
    van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
    Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS).
    Mizukawa Y; Kimishima M; Aoyama Y; Shiohara T
    Int J Infect Dis; 2020 Nov; 100():239-246. PubMed ID: 32891735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and reactivation of latent herpesviruses in older adults.
    Bennett JM; Glaser R; Malarkey WB; Beversdorf DQ; Peng J; Kiecolt-Glaser JK
    Brain Behav Immun; 2012 Jul; 26(5):739-46. PubMed ID: 22155500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient.
    Hemmersbach-Miller M; Alexander BD; Pieper CF; Schmader KE
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):455-463. PubMed ID: 31758441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
    J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
    J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
    Cook CH; Zhang Y; Sedmak DD; Martin LC; Jewell S; Ferguson RM
    Crit Care Med; 2006 Mar; 34(3):842-9. PubMed ID: 16521279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus reactivation in critically ill immunocompetent patients.
    Limaye AP; Kirby KA; Rubenfeld GD; Leisenring WM; Bulger EM; Neff MJ; Gibran NS; Huang ML; Santo Hayes TK; Corey L; Boeckh M
    JAMA; 2008 Jul; 300(4):413-22. PubMed ID: 18647984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus reactivation in patients with multiple myeloma.
    Hasegawa T; Aisa Y; Shimazaki K; Ito C; Nakazato T
    Eur J Haematol; 2016 Jan; 96(1):78-82. PubMed ID: 25810117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseases.
    Hanaoka R; Kurasawa K; Maezawa R; Kumano K; Arai S; Fukuda T
    Mod Rheumatol; 2012 Jun; 22(3):438-45. PubMed ID: 21915676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Reddy V; Meier-Kriesche HU; Greene S; Schold JD; Wingard JR
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):698-705. PubMed ID: 16125640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.